<p>Akari Therapeutics 获得澳大利亚专利批准，进一步扩展其专有 PH1 RNA 剪接调节剂 ADC 载荷的全球保护 | AKTX 股票新闻</p>

Akari治疗

<p>Akari Therapeutics 获得澳大利亚专利批准，进一步扩展其专有 PH1 RNA 剪接调节剂 ADC 载体的全球保护 | AKTX 股票新闻</p>

<p>Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload | AKTX Stock News</p>
<div class="lb-trans"><p>Akari Therapeutics 获得澳大利亚专利批准，进一步扩展其专有 PH1 RNA 剪接调节剂 ADC 载荷的全球保护 | AKTX 股票新闻</p>
</div>

Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload | AKTX Stock News

Akari 治疗公司获得澳大利亚专利批准，进一步扩大其专有 PH1 RNA 剪接调节剂 ADC 有效载荷的全球保护 | AKTX 股票新闻